Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/63474
Type
ArticleCopyright
Open access
Sustainable Development Goals
03 Saúde e Bem-Estar09 Indústria, inovação e infraestrutura
17 Parcerias e meios de implementação
Collections
- IOC - Artigos de Periódicos [12776]
Metadata
Show full item record
GLOBAL LANDSCAPE OF COXSACKIEVIRUSES IN HUMAN HEALTH
Coxsackievirus
Cv-associated infections
Surveillance
Human diseases
Coxsackieviruses in human health
Affilliation
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia e Parasitologia Molecular. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Programa de Pós-Graduação em Medicina Tropical. Rio de Janeiro, RJ, Brasil / Instituto Evandro Chagas. Seção de Virologia. Laboratório de Referência Regional em Enteroviroses. Ananindeua, PA, Brasil.
Instituto Evandro Chagas. Seção de Virologia. Laboratório de Referência Regional em Enteroviroses. Ananindeua, PA, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia e Parasitologia Molecular. Rio de Janeiro, RJ, Brasil.
Instituto Evandro Chagas. Seção de Virologia. Laboratório de Referência Regional em Enteroviroses. Ananindeua, PA, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia e Parasitologia Molecular. Rio de Janeiro, RJ, Brasil.
Abstract
Coxsackieviruses-induced infections, particularly in infants and young children, are one of the most important public health issues in low- and middle-income countries, where the surveillance system varies substantially, and these manifestations have been disregarded. They are widespread throughout the world and are responsible for a broad spectrum of human diseases, from mildly symptomatic conditions to severe acute and chronic disorders. Coxsackieviruses (CV) have been found to have 27 identified genotypes, with overlaps in clinical phenotypes between genotypes. In this review, we present a concise overview of the most recent studies and findings of coxsackieviruses-associated disorders, along with epidemiological data that provides comprehensive details on the distribution, variability, and clinical manifestations of different CV types. We also highlight the significant roles that CV infections play in the emergence of neurodegenerative illnesses and their effects on neurocognition. The current role of CVs in oncolytic virotherapy is also mentioned. This review provides readers with a better understanding of coxsackieviruses-associated disorders and pointing the impact that CV infections can have on different organs with variable pathogenicity. A deeper knowledge of these infections could have implications in designing current surveillance and prevention strategies related to severe CVs-caused infections, as well as encourage studies to identify the emergence of more pathogenic types and the etiology of the most common and most severe disorders associated with coxsackievirus infection
Keywords
EnterovirusCoxsackievirus
Cv-associated infections
Surveillance
Human diseases
Coxsackieviruses in human health
Share